ReportsWorldwide.com Announces Distribution of Publisher MP Advisors Reports

As the leading distributor of market intelligence, ReportsWorldwide.com is pleased to announce a business partnership with MP Advisors which allows for the marketing and distribution of research reports published by MP Advisors through the ReportsWorldwide.com website.

“Our ability to join hands with exceptional research publishers such as MP Advisors allows us to not only broaden the scope of research available in the Pharmaceutical and Biotech industry, it also allows business professionals throughout the world easier access to investment grade reports of great value that they may have previously been unaware of in this field,” stated Abigail Crasto, Senior Vice Presidentat ReportsWorldwide.com.

Commenting on the partnership agreement, Jagdish Gohil, Manager Business Development, MP Advisors said: “Our boutique global pharma & biotech advisory firm since 1998 is happy to collaborate with Reports Worldwide. We are confident that Reports worldwide will support our business growth initiatives and enable us to reach our customers, partners and other key stakeholders in real time, we appreciate Reports worldwide initiatives and wish them all the best.”

To see all their reports, visit: http://bit.ly/2ekBFCm

Some of MP Advisor’s recent reports include:

LARGE CAP PHARMA US & EU OUTLOOK 2016 : MAXIMIZING THEIR STRENGTH ON FEWER THERAPY CLASS, PERSONALIZED MEDICINE, NOVEL TARGET AND BIOSIMILARS FOR FUTURE GROWTH
This report provides analyses of individual large cap companies, promising drug candidates in their late stage pipelines, competitive landscape, and important therapy areas where new innovation will create leadership, forecast for major marketed drugs where competition/ regulatory scenario will change the dynamics, and the potential impact of several important upcoming milestones on the industry.

INDIA PHARMA OUTLOOK 2016: MILESTONES TO WATCH – GROWTH FROM EXPORTS AND DOMESTIC GETTING BETTER, IMPLEMENTATION OF POLICIES UNDER “MAKE-IN-INDIA”, OVERTURE OF A NEW MINISTRY
2016 will be a crucial for drug makers and consumers. During ‘Make-in-India’ week in Mumbai, the Government of India has highlighted many amendments or introduction of new policies with an aim to make India as a major hub for end to end drug discovery. To boost drug discovery, to promote manufacturing of certain drugs against life threatening diseases like AIDS, and to reduce dependence on China, the Govt. has promised to offer many incentives (exemption from excise duty or tax) and also plans to setup venture capital funds, cluster developments to strengthen pharma infrastructure / business.

JAPAN PHARMA OUTLOOK 2016 : JP GIANTS LEANING IN FOR BECOMING A SPECIALITY GLOBAL PHARMA
This report analyses therapy focus, changing strategies, pipeline and key growth drivers of 12 major Japanese biopharma companies (Pure play innovators/ Innovators+ Generics/Pure play generics) and detaits a view on their strategic action to withstand in domestic market and expand globally with their interest for in licensing external innovation from the globe for increasing R&D productivity and priorities on M & A side.

About ReportsWorldwide.com

ReportsWorldwide.com is a leading provider of global market intelligence reports and services. With research reports from top publishers, consulting and advisory firms, ReportsWorldwide.com offers instant online access to a growing database of expert insights on global industries, companies, products, geographies and trends. Moreover, ReportsWorldwide's Research Associates have in-depth knowledge of the reports and services on offer and are ready to provide assistance

Press Contact:
Abigail Crasto
Senior Vice President
101, Arch Street
Boston, MA 02110
US
Phone +1 (617) 398-4994
Fax +1 (617) 398-4995
abigail@reportsworldwide.com

This release was published on openPR.